60P Deep learning-based digital pathology for risk stratification of atypical ductal hyperplasia/ductal carcinoma in situ
Chung‐Yen Huang, C-C. Lee, Chun-Yi Lin, RF Chang, P-C. Liao, P-Y. Lin, Y-H. Lee · ESMO Open · 2023
Clinical trials are exploring the possibility of active surveillance for low-risk ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH). However, interobserver variability in grading DCIS exists. We aim to train and evaluate a deep learning model (Deep DCIS) on breast biopsy with ADH/DCIS to improve the risk stratification of these precursor lesions.